Risk factors for post‐ERCP pancreatitis and hyperamylasemia: A retrospective single‐center study

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|16|8|471-478

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.16, Iss.8, 2015-08, pp. : 471-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotide effectively reduces the incidence of post-ERCP pancreatitis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

NSAIDs may but allopurinol may not prevent post-ERCP pancreatitis

By  

Inpharma, Vol. 1, Iss. 1658, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Combination of rituximab and nonpegylated liposomal doxorubicin (R‐NPLD) as front‐line therapy for aggressive non‐Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single‐center retrospective study

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 44-48

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors of acute pancreatitis in the elderly Chinese population: A population‐based cross‐sectional study

By  

Journal of Digestive Diseases, Vol. 15, Iss. 9, 2014-09 ,pp. : 501-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ranitidine (Zantac®) Syrup versus Ranitidine Effervescent Tablets (Zantac® EFFERdose®) in Children: A Single-Center Taste Preference Study

By Ameen Vanessa Z.  

Pediatric Drugs, Vol. 8, Iss. 4, 2006-01 ,pp. : 265-270

Adis International

Access to resources Recommend Favorite